Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
MacSports Research Program, McMaster University, Hamilton, Ontario, Canada.
Arthroscopy. 2021 Jul;37(7):2361-2376.e1. doi: 10.1016/j.arthro.2021.03.031. Epub 2021 Mar 23.
The aim of this systematic review was to evaluate the impact of bone grafting of patellar defects on reported anterior knee morbidity and subjective outcomes after bone-patellar tendon-bone autograft reconstruction of the anterior cruciate ligament.
A systematic electronic search of MEDLINE, Embase, Web of Science, and the Cochrane Library was carried out. All English-language prospective randomized clinical trials published from January 1, 2000, to July 24, 2020, were eligible for inclusion. All studies addressing patellar defect grafting were eligible for inclusion regardless of the timing of surgery, graft type, surgical technique, or rehabilitation protocol.
A total of 39 studies with 1,955 patients were included for analysis. There were 796 patients in the no patellar grafting (NPG) group, with a mean age range of 22.7 to 33.0 years, and 1,159 patients in the patellar grafting (PG) group, with a mean age range of 17.8 to 34.7 years. The visual analog scale pain score ranged from 1.2 to 5.1 in the NPG group compared with 0.3 to 3.7 in the PG group. The proportion of patients with anterior knee pain ranged from 19% to 81% in the NPG group and from 15% to 32% in the PG group. Moderate to severe kneeling pain was reported in 22% to 57% of patients in the NPG group and 10% of those in the PG group. The percentage of patients with at least 3° of extension loss ranged from 4% to 43% in the NPG group and from 2% to 11% in the PG group.
PG favors decreased anterior knee pain, kneeling pain, and extension loss compared with non-grafted defects; however, the functional outcomes are comparable. Owing to the heterogeneity in reporting, statistical conclusions could not be drawn.
Level II, systematic review of Level I and II studies.
本系统评价旨在评估髌股缺损植骨对骨-髌腱-骨自体重建前交叉韧带后报告的前膝发病率和主观结果的影响。
对 MEDLINE、Embase、Web of Science 和 Cochrane 图书馆进行了系统的电子检索。所有 2000 年 1 月 1 日至 2020 年 7 月 24 日发表的英文前瞻性随机临床试验均符合纳入标准。所有涉及髌股缺损植骨的研究均符合纳入标准,无论手术时机、移植物类型、手术技术或康复方案如何。
共纳入 39 项研究 1955 例患者进行分析。无髌股植骨(NPG)组 796 例,年龄范围 22.7 岁至 33.0 岁;髌股植骨(PG)组 1159 例,年龄范围 17.8 岁至 34.7 岁。NPG 组视觉模拟评分疼痛范围为 1.2 至 5.1,PG 组为 0.3 至 3.7。NPG 组有前膝痛的患者比例为 19%至 81%,PG 组为 15%至 32%。NPG 组中度至重度跪地疼痛的患者比例为 22%至 57%,PG 组为 10%。NPG 组至少有 3°伸展丧失的患者比例为 4%至 43%,PG 组为 2%至 11%。
与非植骨缺损相比,PG 有利于减少前膝痛、跪地痛和伸展丧失;然而,功能结果相当。由于报告存在异质性,无法得出统计学结论。
II 级,对 I 级和 II 级研究的系统评价。